Literature DB >> 34952863

Shifts in preference for Natural American Spirit and associated belief that one's own cigarette brand might be less harmful than other brands: results from Waves 1-4 of the Population Assessment of Tobacco and Health (PATH) Study (2013-2018).

Jennifer Pearson1,2, Ollie Ganz3,4, Pamela Ohman-Strickland5, Olivia A Wackowski3.   

Abstract

INTRODUCTION: People believe that cigarettes using 'organic,' 'additive-free' or similar descriptors are less harmful than other cigarettes. Natural American Spirit (NAS) is the most popular US cigarette brand using these descriptors. This cohort study describes changes in US smokers' odds of preferring NAS and changes in NAS smokers' odds of believing their brand might be less harmful than other brands.
METHODS: Data come from four waves (2013-2018) of the Population Assessment of Tobacco and Health (PATH) Study. Generalised estimating equations produced population-averaged estimates of relationships between (1) NAS brand preference and wave and (2) belief that one's own brand might be less harmful than other brands, wave and NAS brand preference. Models tested interactions by age group and sexual minority status.
RESULTS: The odds that smokers preferred NAS increased by 60% in W4 relative to W1. Disproportionate preference by younger adult and sexual minority smokers was observed. The odds that NAS smokers believed their own brand might be less harmful decreased by 50% between W1 and W4, but this perception was still 16 times higher for NAS compared with non-NAS smokers. Given the increasing preference for NAS, there was no significant change in the absolute number of NAS smokers who believed their own brand might be less harmful (W1: 562 122 (95% CI 435 190 to 689 055) vs W4: 580 378 (95% CI 441 069 to 719 689)).
CONCLUSIONS: Both brand popularity and concentration of brand-related harm perceptions are important for understanding population impact of changes in cigarette marketing. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  disparities; packaging and labelling; priority/special populations; public policy

Year:  2021        PMID: 34952863      PMCID: PMC9290335          DOI: 10.1136/tobaccocontrol-2021-056985

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   6.953


  18 in total

1.  Winston's "No Additives" campaign: "straight up"? "no bull"?

Authors:  J J Arnett
Journal:  Public Health Rep       Date:  1999 Nov-Dec       Impact factor: 2.792

2.  Correlates of tobacco product cessation among youth and adults in the USA: findings from the PATH Study Waves 1-3 (2013-2016).

Authors:  Karin A Kasza; Kathryn C Edwards; Zhiqun Tang; Cassandra A Stanton; Eva Sharma; Michael J Halenar; Kristie A Taylor; Elisabeth A Donaldson; Lynn C Hull; Maansi Bansal-Travers; Jean Limpert; Izabella Zandberg; Lisa D Gardner; Hoda T Hammad; Nicolette Borek; Heather L Kimmel; Wilson M Compton; Andrew Hyland
Journal:  Tob Control       Date:  2020-05       Impact factor: 7.552

3.  Misperceptions of harm among Natural American Spirit smokers: results from wave 1 of the Population Assessment of Tobacco and Health (PATH) study (2013-2014).

Authors:  Jennifer L Pearson; Amanda Johnson; Andrea Villanti; Allison M Glasser; Lauren Collins; Amy Cohn; Shyanika W Rose; Raymond Niaura; Cassandra A Stanton
Journal:  Tob Control       Date:  2016-12-06       Impact factor: 7.552

4.  Standardised cigarette packaging may reduce the implied safety of Natural American Spirit cigarettes.

Authors:  Eric Craig Leas; John P Pierce; Claudiu V Dimofte; Dennis R Trinidad; David R Strong
Journal:  Tob Control       Date:  2017-12-18       Impact factor: 7.552

5.  Adolescents' and adults' perceptions of 'natural', 'organic' and 'additive-free' cigarettes, and the required disclaimers.

Authors:  M Justin Byron; Sabeeh A Baig; Kathryn E Moracco; Noel T Brewer
Journal:  Tob Control       Date:  2015-12-01       Impact factor: 7.552

6.  American Spirit Pack Descriptors and Perceptions of Harm: A Crowdsourced Comparison of Modified Packs.

Authors:  Jennifer L Pearson; Amanda Richardson; Shari P Feirman; Andrea C Villanti; Jennifer Cantrell; Amy Cohn; Michael Tacelosky; Thomas R Kirchner
Journal:  Nicotine Tob Res       Date:  2016-05-10       Impact factor: 4.244

7.  Design and methods of the Population Assessment of Tobacco and Health (PATH) Study.

Authors:  Andrew Hyland; Bridget K Ambrose; Kevin P Conway; Nicolette Borek; Elizabeth Lambert; Charles Carusi; Kristie Taylor; Scott Crosse; Geoffrey T Fong; K Michael Cummings; David Abrams; John P Pierce; James Sargent; Karen Messer; Maansi Bansal-Travers; Ray Niaura; Donna Vallone; David Hammond; Nahla Hilmi; Jonathan Kwan; Andrea Piesse; Graham Kalton; Sharon Lohr; Nick Pharris-Ciurej; Victoria Castleman; Victoria R Green; Greta Tessman; Annette Kaufman; Charles Lawrence; Dana M van Bemmel; Heather L Kimmel; Ben Blount; Ling Yang; Barbara O'Brien; Cindy Tworek; Derek Alberding; Lynn C Hull; Yu-Ching Cheng; David Maklan; Cathy L Backinger; Wilson M Compton
Journal:  Tob Control       Date:  2016-08-08       Impact factor: 7.552

8.  Perceptions of "Natural" and "Additive-Free" Cigarettes and Intentions to Purchase.

Authors:  Richard J O'Connor; M Jane Lewis; Sarah E Adkison; Maansi Bansal-Travers; K Michael Cummings
Journal:  Health Educ Behav       Date:  2016-07-09

9.  Trends in market share of leading cigarette brands in the USA: national survey on drug use and health 2002-2013.

Authors:  Anushree Sharma; Brian V Fix; Cristine Delnevo; K Michael Cummings; Richard J O'Connor
Journal:  BMJ Open       Date:  2016-01-29       Impact factor: 2.692

10.  Association of Coming Out as Lesbian, Gay, and Bisexual+ and Risk of Cigarette Smoking in a Nationally Representative Sample of Youth and Young Adults.

Authors:  Alyssa F Harlow; Dielle Lundberg; Julia R Raifman; Andy S L Tan; Carl G Streed; Emelia J Benjamin; Andrew C Stokes
Journal:  JAMA Pediatr       Date:  2021-01-01       Impact factor: 16.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.